Pulmotect, Inc. Email Format
Biotechnology ResearchTexas, United States2-10 Employees
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.